NCT05205343 Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers
| NCT ID | NCT05205343 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Gastrostomy |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2022-05-11 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2022-05-11 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.
Eligibility Criteria
Inclusion: 1. Able to speak and read English, Spanish, Japanese or Korean 2. Participants with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention 3. Age ≥ 18 Exclusion: 1. Participants with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract 2. Participants with known narcotic dependence, with average daily dose \> 5 mg oral morphine equivalent 3. Participants deemed unable to comply with study and/or follow-up procedures, at investigators' discretion 4. Participants who are pregnant (since are excluded from receiving standard-of-care MIPG or MITG)
Contact & Investigator
Naruhiko Ikoma, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT05205343 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gastrostomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05205343 currently recruiting?
Yes, NCT05205343 is actively recruiting participants. Contact the research team at nikoma@mdanderson.org for enrollment information.
Where is the NCT05205343 trial being conducted?
This trial is being conducted at Rochester, United States, Houston, United States, Tokyo, Japan, Soeul, South Korea.
Who is sponsoring the NCT05205343 clinical trial?
NCT05205343 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Naruhiko Ikoma, MD at M.D. Anderson Cancer Center. The trial plans to enroll 20 participants.